NCT06295302View on ClinicalTrials.gov

A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Chronic Spontaneous Urticaria
Interventions
DRUG

HWH486

HWH486 capsule was administrated orally

DRUG

Placebo

Matching placebo was administrated orally

Trial Locations (1)

Unknown

RECRUITING

West China Hospital,Sichuan University, Chengdu

All Listed Sponsors
lead

Hubei Biological Medicine Industrial Technology Institute Co., Ltd.

OTHER